Effect of ramipril on the incidence of diabetes.

Effect of ramipril on the incidence of diabetes.

BACKGROUND: Previous studies have suggested that blockade of the renin-angiotensin system may prevent diabetes in people with cardiovascular disease or hypertension. METHODS: In a double-blind, randomized clinical trial with a 2-by-2 factorial design, we randomly assigned 5269 participants without...

Bibliografiset tiedot
Päätekijät:	Bosch, J, Yusuf, S, Gerstein, H, Pogue, J, Sheridan, P, Dagenais, G, Diaz, R, Avezum, A, Lanas, F, Probstfield, J, Fodor, G, Holman, R
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2006

Samankaltaisia teoksia

Incidence of diabetes following ramipril or rosiglitazone withdrawal
Tekijä: Holman, R, et al.
Julkaistu: (2011)

Incidence of diabetes following ramipril or rosiglitazone withdrawal.
Tekijä: Investigators, D
Julkaistu: (2011)

Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial.
Tekijä: Punthakee, Z, et al.
Julkaistu: (2012)

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
Tekijä: Gerstein, H, et al.
Julkaistu: (2006)

A Comparative Evaluation of Ramipril as Monotherapy and Combination of Ramipril with Torsemide in Hypertension
Tekijä: Navjot Kaur, et al.
Julkaistu: (2017-11-01)

Trial update: the Diabetes REduction Approaches with ramipril and rosiglitazone Medications (DREAM) trial
Tekijä: G. Gulli
Julkaistu: (2013-05-01)

Ramipril induced pemphigoid vulgaris
Tekijä: Mirza MA, et al.
Julkaistu: (2018-09-01)

Effect of ramipril/hydrochlorothiazide and ramipril/canrenone combination on atrial fibrillation recurrence in hypertensive type 2 diabetic patients with and without cardiac autonomic neuropathy
Tekijä: Daniele Bosone, et al.
Julkaistu: (2016-09-01)

Ramipril therapy in acute myocardial infarction
Tekijä: V. A. Lusov, et al.
Julkaistu: (2008-10-01)

Ramipril poisoning rescued by naloxone and terlipressin
Tekijä: Samanta Samanta, et al.
Julkaistu: (2014-01-01)

The Degradation Product of Ramipril Is Potentially Carcinogenic, Genotoxic and Mutagenic
Tekijä: Katarzyna Regulska, et al.
Julkaistu: (2023-02-01)

Effect of ramipril on renal function in patients with intermittent claudication
Tekijä: Simon D Hobbs, et al.
Julkaistu: (2008-04-01)

A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes
Tekijä: Hertzel C. Gerstein, et al.
Julkaistu: (2022-08-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
Tekijä: I. V. Szirov, et al.
Julkaistu: (2015-12-01)

FIXED COMBINATION OF RAMIPRIL AND HYDROCHLOROTHIAZIDE: TO WHOM AND WHAT FOR?
Tekijä: S. V. Nedogoda
Julkaistu: (2016-09-01)

Development of Methods of Quality Control of the Tablets «Ramipril»
Tekijä: Kateryna Typlynska, et al.
Julkaistu: (2023-04-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
Tekijä: I. V. Szirov, et al.
Julkaistu: (2015-12-01)

V fokuse vnimaniya - ingibitoryangiotenzinprevrashchayushchegofermenta: ramipril priarterial'noy gipertonii
Tekijä: I E Chazova, et al.
Julkaistu: (2011-09-01)

Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: Results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial
Julkaistu: (2008)

The place of ramipril in modern guidelines for the management of patients with cardiovascular diseases
Tekijä: E. E. Averin, et al.
Julkaistu: (2019-01-01)

RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS
Tekijä: S. R. Willoughby, et al.
Julkaistu: (2015-12-01)

RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS
Tekijä: S. R. Willoughby, et al.
Julkaistu: (2015-12-01)

Comparison of the efficacy, safety and tolerability of ramipril with amlodipine in treatment of mild to moderate hypertension in Nigerians
Tekijä: B J C Onwubere, et al.
Julkaistu: (2007-01-01)

MARRIAGE: A Randomized Trial of Moxonidine Ramipril or in Combination With Ramipril in Overweight Patients With Hypertension and Impaired Fasting Glucose or Diabetes Mellitus. Impact on Blood Pressure, Heart Rate and Metabolic Parameters
Tekijä: Paul Valensi MD, et al.
Julkaistu: (2024-06-01)

Three-dimensional printing of ramipril tablets by fused deposition modeling
Tekijä: O. A. Terenteva, et al.
Julkaistu: (2021-12-01)

Effect of Valsartan on the Incidence of Diabetes REPLY
Tekijä: Holman, R, et al.
Julkaistu: (2010)

Comparative effectiveness of fixed combinations of various ramipril and hydrochlorothiazide doses
Tekijä: I. E. Chazova, et al.
Julkaistu: (2010-08-01)

THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
Tekijä: V. I. Podzolkov, et al.
Julkaistu: (2015-09-01)

THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
Tekijä: V. I. Podzolkov, et al.
Julkaistu: (2015-09-01)

Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored.
Tekijä: McMurray, J, et al.
Julkaistu: (2014)

Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL Study (Diabete, Ipertensione, Albuminuria, Lercanidipina)
Tekijä: M. Dalla Vestra, et al.
Julkaistu: (1970-01-01)

RAMIPRIL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE
Tekijä: A. I. Chesnikova, et al.
Julkaistu: (2016-01-01)

Solid-State Stability Profiling of Ramipril to Optimize Its Quality Efficiency and Safety
Tekijä: Katarzyna Regulska, et al.
Julkaistu: (2021-10-01)

ESTIMATION OF NEPHROPROTECTIVE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME RAMIPRIL IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS
Tekijä: M.A. Dolinnayä, et al.
Julkaistu: (2017-03-01)

CHANGES IN CLINICAL MANIFESTATION OF CONGESTIVE HEART FAILURE AT THE BACKGROUND OF REGULAR RAMIPRIL INTAKE
Tekijä: A. G. Kuzmin, et al.
Julkaistu: (2014-08-01)

Efficiency (advantages) of ramipril in arterial hypertension and diabetes mellitus from the point of view of evidence-based medicine
Tekijä: M. V. Leonova
Julkaistu: (2020-05-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
Tekijä: D. A. Napalkov, et al.
Julkaistu: (2016-01-01)

DISSOLUTION PROFILE STUDIES FOR RAMIPRIL AND LERCANIDIPINE FIXED-DOSE COMBINATION
Tekijä: A. A. Shadrin, et al.
Julkaistu: (2019-01-01)

The effects of sacubitril/valsartan and ramipril on the male fertility in hypertensive rats
Tekijä: Duygun Altıntaş Aykan, et al.
Julkaistu: (2020-10-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
Tekijä: D. A. Napalkov, et al.
Julkaistu: (2016-01-01)